These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Therapeutic drug monitoring of phenytoin. Rationale and current status. Levine M; Chang T Clin Pharmacokinet; 1990 Nov; 19(5):341-58. PubMed ID: 2268985 [No Abstract] [Full Text] [Related]
29. [Phenytoin and phenytoin derivatives for local administration]. Fürst W; Wildner R Pharmazie; 1991 Jun; 46(6):424-6. PubMed ID: 1763120 [TBL] [Abstract][Full Text] [Related]
30. Phenytoin suppositories and echinacea. Kaatz B S D J Med; 1997 Sep; 50(9):335. PubMed ID: 9314727 [No Abstract] [Full Text] [Related]
31. Applicability of phenytoin predictive formulas to long-term-care facility residents. Drinka PJ; Miller J; Voeks SK Clin Pharm; 1988 Jul; 7(7):497-8. PubMed ID: 3138061 [No Abstract] [Full Text] [Related]
32. Influence of the emulsion sign in phenytoin bioavailability. Savio EO; Fagiolino P; Jelen M; León AS Boll Chim Farm; 1994 Apr; 133(4):239-45. PubMed ID: 8068235 [TBL] [Abstract][Full Text] [Related]
37. Dosing and therapeutic monitoring of phenytoin in young adults after neurotrauma: are current practices relevant? Frend V; Chetty M Clin Neuropharmacol; 2007; 30(6):362-9. PubMed ID: 18090462 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin. Kim YC; Kang HE; Lee MG Biopharm Drug Dispos; 2008 Jan; 29(1):51-61. PubMed ID: 18022993 [TBL] [Abstract][Full Text] [Related]
40. [The effect of hyperlipidemia on pharmacokinetics of free phenytoin]. Dudkiewicz G; Wójcik J; Gawrońska-Szklarz B Neurol Neurochir Pol; 1994; 28(6):845-52. PubMed ID: 7870258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]